Stock ADO ANTEOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

AnteoTech Limited Stock

Equities

ADO

AU000000ADO8

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 12:10:56 2024-12-13 am EST 		5-day change 1st Jan Change
0.0180 AUD 0.00% Intraday chart for AnteoTech Limited +5.88% -50.00%
Nov. 21 AnteoTech Opens AU$5 Million Entitlement Offer; Shares Up 5% MT
Oct. 29 AnteoTech Secures AU$4 Million Grant to Boost Battery Anode Development; Shares Jump 8% MT

Valuation: AnteoTech Limited

Capitalization 47.97M 30.48M 29.04M 27.23M 24.15M 43.4M 2.59B 335M 124M 1.07B 115M 112M 4.68B P/E ratio 2023
-6.33x
P/E ratio 2024 -5x
Enterprise value 45.27M 28.77M 27.41M 25.7M 22.79M 40.96M 2.44B 316M 117M 1.01B 108M 106M 4.42B EV / Sales 2023
220x
EV / Sales 2024 101x
Free-Float
-
Yield 2023 *
-
Yield 2024 -
More valuation ratios * Estimated data

Chart: AnteoTech Limited

Dynamic Chart

Latest news: AnteoTech Limited

AnteoTech Opens AU$5 Million Entitlement Offer; Shares Up 5% Nov. 20 MT
AnteoTech Secures AU$4 Million Grant to Boost Battery Anode Development; Shares Jump 8% Oct. 28 MT
AnteoTech Secures First Purchase Order for Battery Anode Technology; Shares Up 20% Oct. 14 MT
AnteoTech Limited Reports Earnings Results for the Full Year Ended June 30, 2024 Aug. 27 CI
AnteoTech Limited Auditor Raises 'Going Concern' Doubt Aug. 26 CI
AnteoTech Begins Commercial Evaluation of AnteoBind NXT with India's Vidcare Innovations Aug. 14 MT
AnteoTech Signs Five-Year Purchase Agreement for AnteoBind product; Shares Down Nearly 5% Jul. 30 MT
AnteoTech Completes AU$1.4 Million Share Purchase Plan May. 14 MT
AnteoTech Extends Closing Date of Share Purchase Plan May. 01 MT
Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26% Apr. 08 MT
AnteoTech Receives AU$1.39 Million from Queensland Critical Minerals and Battery Technology Fund; Shares Down 3% Mar. 26 MT
AnteoTech Settles Patent Claims for AU$300,000 Mar. 04 MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2023 Feb. 27 CI
More news

Press Releases: AnteoTech Limited

AnteoTech : Application for quotation of securities - ADO 22-06-13 PU
AnteoTech : Quarterly Update and Appendix 4C 22-04-20 PU
AnteoTech : Presentation to International Battery Seminar 22-03-31 PU
AnteoTech : Application for quotation of securities - ADO 22-03-20 PU
AnteoTech : Response to ASX Query Letter 22-03-20 PU
More press releases

Quotes and Performance

1 week+5.88%
1 month-33.33%
3 months-25.00%
6 months-18.18%
Current year-50.00%
More quotes

Course Extremes

1 week
0.02
Extreme 0.016
0.02
1 month
0.02
Extreme 0.016
0.02
Current year
0.02
Extreme 0.016
0.04
1 year
0.02
Extreme 0.016
0.04
3 years
0.02
Extreme 0.016
0.42
5 years
0.01
Extreme 0.01
0.50
10 years
0.01
Extreme 0.008
0.50
More quotes

Managers and Directors: AnteoTech Limited

Director TitleAgeSince
David Radford CEO
 Chief Executive Officer - 2022-10-03
Nobuyoshi Maeji CTO
 Chief Tech/Sci/R&D Officer - 2009-11-02
Andrew Cook DFI
 Director of Finance/CFO - 2023-08-27
Manager TitleAgeSince
Geoff Cumming BRD
 Director/Board Member - 2009-04-01
Glenda McLoughlin BRD
 Director/Board Member - 2021-08-31
Katherine Woodthorpe BRD
 Director/Board Member - 2021-08-31
More insiders

Other Biotechnology & Medical Research

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
ANTEOTECH LIMITED Stock AnteoTech Limited
0.00%+5.88%-47.06%-90.00%30.62M
LONZA GROUP AG Stock Lonza Group AG
-2.81%+2.03%+63.44%-28.21%44.57B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.47%-1.79%-11.92%-26.22%36.37B
CELLTRION, INC. Stock Celltrion, Inc.
+4.60%+6.85%+5.45%-1.37%26.67B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
-1.27%-4.44%-25.02%-25.13%17.4B
MODERNA, INC. Stock Moderna, Inc.
-2.02%-4.58%-46.05%-84.41%16.48B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
-0.38%-2.42%+40.39%+88.65%16.14B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-2.37%+0.70%+1.39%-36.19%12.18B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
-0.63%-1.12%+16.65%+68.04%10.77B
QIAGEN N.V. Stock Qiagen N.V.
-1.10%+4.72%+2.38%-19.49%10.21B
Average -0.65%+3.00%-0.04%-15.43% 19.08B
Weighted average by Cap. -0.66%+3.15%+11.61%-13.39%
See all sector performances

Financials

2023 2024
Net sales 366K 232K 221K 208K 184K 331K 19.71M 2.55M 944K 8.12M 873K 854K 35.71M 460K 293K 279K 261K 232K 417K 24.82M 3.21M 1.19M 10.23M 1.1M 1.07M 44.96M
Net income -12.65M -8.04M -7.66M -7.18M -6.37M -11.45M -682M -88.33M -32.67M -281M -30.22M -29.54M -1.24B -8.88M -5.64M -5.38M -5.04M -4.47M -8.03M -479M -61.99M -22.93M -197M -21.21M -20.73M -867M
Net Debt -1.41M -898K -856K -802K -712K -1.28M -76.2M -9.87M -3.65M -31.4M -3.38M -3.3M -138M -2.69M -1.71M -1.63M -1.53M -1.35M -2.43M -145M -18.78M -6.95M -59.76M -6.43M -6.28M -263M
More financial data * Estimated data

Company Profile

Logo AnteoTech Limited
AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.
Employees
99
Sector
Biotechnology & Medical Research
Calendar
2025-02-25 - Q2 2025 Earnings Release (Projected)
More about the company

Quotes

Date Price Change Volume
24-12-13 0.0180 $ 0.00% 8,797,077
24-12-12 0.0180 $ 0.00% 6,072,888
24-12-11 0.0180 $ -5.26% 2,209,630
24-12-10 0.0190 $ +2.70% 3,601,753
24-12-09 0.0185 $ -2.63% 3,505,584

Delayed Quote Australian S.E., December 13, 2024 at 12:10 am EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart ANTEOTECH-LIMITED More financial data
  1. Stock Market
  2. Equities
  3. ADO Stock